Recently approved and experimental methods of contraception.

Area of Science:

• Reproductive Health
• Pharmacology and Drug Development
• Medical Devices

Background:

• The U.S. Food and Drug Administration (FDA) has recently approved novel contraceptive options.
• Several innovative contraceptive approaches are currently under active investigation.
• There is an ongoing need for diverse and effective family planning methods.

Purpose of the Study:

• To provide comprehensive details on the latest contraceptive methods available and under investigation.
• To review recently approved and emerging contraceptive technologies for public awareness.

Main Methods:

• Review of U.S. Food and Drug Administration (FDA) approved contraceptive devices.
• Summary of emerging contraceptive technologies including hormonal and non-hormonal methods.
• Inclusion of experimental male contraceptive approaches and contraceptive vaccines.

Main Results:

• Recent FDA approvals include the Paragard Copper T 380A intrauterine device and NORPLANT.
• Other methods nearing approval include the cervical cap, vaginal pouch, long-acting injectables, hormonal vaginal ring, and transdermal patch.
• Experimental male methods, inhibin, and contraceptive vaccines are under investigation.

Conclusions:

• A growing number of contraceptive options are becoming available to the public.
• Continued research promises further advancements in reproductive health and family planning.
• The landscape of contraception is expanding with diverse and innovative approaches.